Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best ... Amgen successfully launched two next-generation products ...
Some investors believe you make money when you buy a stock, not when you sell it. The logic behind this idea is that ...
Hosted on MSN5d
Why Amgen (AMGN) is a Top Momentum Stock for the Long-TermIt rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast ... blood cell stimulant). Amgen successfully launched ...
The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.
As 2024 has come and passed, we saw another year of significant developments in litigation involving biologics and biosimilars. The ...
Oppenheimer analyst Jay Olson maintained a Buy rating on Exelixis (EXEL – Research Report) today and set a price target of $41.00. The ...
In a report released today, Yaron Werber from TD Cowen maintained a Buy rating on Exelixis (EXEL – Research Report), with a price target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback